share_log

Alaunos Therapeutics analyst ratings

アラノス・セラピューティクスのアナリスト評価

Benzinga Analyst Ratings ·  2022/07/15 08:41
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/15/2022 114.29% Cantor Fitzgerald → $3 Assumes → Overweight
05/04/2022 114.29% Wells Fargo → $3 Upgrades Equal-Weight → Overweight

Alaunos Therapeutics Questions & Answers

What is the target price for Alaunos Therapeutics (TCRT)?

The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by Cantor Fitzgerald on July 15, 2022. The analyst firm set a price target for $3.00 expecting TCRT to rise to within 12 months (a possible 114.29% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Alaunos Therapeutics (TCRT)?

The latest analyst rating for Alaunos Therapeutics (NASDAQ: TCRT) was provided by Cantor Fitzgerald, and Alaunos Therapeutics their overweight rating.

When is the next analyst rating going to be posted or updated for Alaunos Therapeutics (TCRT)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alaunos Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alaunos Therapeutics was filed on July 15, 2022 so you should expect the next rating to be made available sometime around July 15, 2023.

Is the Analyst Rating Alaunos Therapeutics (TCRT) correct?

While ratings are subjective and will change, the latest Alaunos Therapeutics (TCRT) rating was a with a price target of $0.00 to $3.00. The current price Alaunos Therapeutics (TCRT) is trading at is $1.40, which is within the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする